WPD Pharmaceuticals (TSE:WBIO) has released an update.
WPD Pharmaceuticals has reached an agreement with its CEO, a director, and a former director to convert 60% of its debt owed to them into equity, issuing over 1.2 million common shares at $0.05 each. Additionally, the company settled debt with a third-party creditor by issuing 100,000 common shares at the same price. These shares for debt transactions, considered related party transactions, comply with securities laws and will be held for a four-month period before they can be traded.
For further insights into TSE:WBIO stock, check out TipRanks’ Stock Analysis page.
